MORE►
Drew Walk
Drew Walk, CEO of Soleo Health [Courtesy photo; DI]
Soleo Health CEO Named to National Home Infusion Association Board
by Lance Murray | Mar 22, 2023
Through his board position, Drew Walk hopes to advance key issues in healthcare industry such as adapting to regulatory changes, improving reimbursement practices, and promoting the use of technology in patient-provider and patient-pharmacy communication, especially with the rise of telehealth initiatives.
by Lance Murray |
Feb 10, 2023
Susan Faust has been appointed to the newly created role of chief strategy officer by Frisco-based Soleo Health, a national provider of complex specialty pharmacy services.
In her new role, Faust will guide Soleo Health’s strategic initiatives, expanding its position with pharmaceutical manufacturers, payors, health systems, and providers, Soleo said.
“We created the chief strategy officer position because we believe our recent growth warranted the development and implementation of cohesive, dedicated strategic initiatives to take our company to the next level,” Drew Walk, Soleo Health chief executive officer, said in a statement....
MORE►
by David Seeley |
Jan 18, 2023
Frisco-based pharmacy services provider Soleo Health has been selected by Eisai Inc. as the sole specialty pharmacy distribution partner for Leqembi (lecanemab-irmb), a newly FDA-approved treatment for early and mild stages of Alzheimer’s Disease.
Soleo Health CEO Drew Walk says the partnership "will afford the Alzheimer’s community continued hope while we assist patients and their caregivers as they navigate their healthcare journey."
MORE►
by David Kirkpatrick |
Jan 31, 2022
Only five other U.S. companies have received ACHC accreditation as specialized pharmacies with distinction in rare disease and orphan drugs. Founded in 2014, Soleo debuted on the Inc. 5000 for the first time in 2020. With 20 locations nationwide, Soleo delivers specialty pharmacy and infusion services, with a focus on amyotrophic lateral sclerosis (ALS), thyroid eye disease (TED), hemophilia, muscular dystrophy, and myasthenia gravis.
MORE►
